First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain

Gabriela Mladenova, Subhash C. Annedi, Jailall Ramnauth, Shawn P. Maddaford, Suman Rakhit, John S. Andrews, Dongqin Zhang, Frank Porreca

Research output: Contribution to journalArticlepeer-review

15 Scopus citations

Fingerprint Dive into the research topics of 'First-in-class, dual-action, 3,5-disubstituted indole derivatives having human nitric oxide synthase (nNOS) and norepinephrine reuptake inhibitory (NERI) activity for the treatment of neuropathic pain'. Together they form a unique fingerprint.

Medicine & Life Sciences